Hari M. Dhingra
Michael E. DeBakey VA Medical Center · 31 works · 2,921 citations · h-index 17
Top works
- A Randomized Trial Comparing Perioperative Chemotherapy and Surgery With Surgery Alone in Resectable Stage IIIA Non-Small-Cell Lung Cancer
- Phase II Study of Taxol in Patients With Untreated Advanced Non-Small-Cell Lung Cancer
- Long-term follow-up of patients enrolled in a randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer
- Randomized trial of three combinations of cisplatin with vindesine and/or VP-16-213 in the treatment of advanced non-small-cell lung cancer.
- Role of elective brain irradiation during combined chemoradiotherapy for limited disease non-small cell lung cancer
- High-dose intensification therapy with autologous bone marrow support for limited small-cell bronchogenic carcinoma.
- Primary chemotherapy of brain metastasis in small-cell lung cancer.
- Cutaneous and subcutaneous metastases of lung cancer
- Esophageal complications from combined chemoradiotherapy (cyclophosphamide + adriamycin + cisplatin + xrt) in the treatment of non-small cell lung cancer
- High-dose chemotherapy and autologous bone marrow transplantation for the treatment of small cell lung carcinoma
- Phase I trial of oral talactoferrin alfa in refractory solid tumors
- Unusual Sites of Malignancy
- Combined chemoradiotherapy in limited-disease, inoperable non-small cell lung cancer
- Weekly doxorubicinversus doxorubicin every 3 weeks in cyclophosphamide, doxorubicin, and cisplatin chemotherapy for non-small cell lung cancer
- Effects of brain irradiation and chemotherapy on myelosuppression in small-cell lung cancer.
- Chemotherapy for advanced adenocarcinoma and squamous cell carcinoma of the lung with etoposide and cisplatin.
- Use of carcinoembryonic antigen in small cell lung cancer prognostic value and relation to the clinical course 1
- A phase I trial of recombinant alpha-2a Interferon (Roferon-A) with weekly cisplatinum
- Phase II Pilot Study with Cisplatin, Etoposide, and Continuous-Infusion 5-Fluorouracil in Metastatic Non-small Cell Lung Cancer
- Phase II trial of 5,6-dihydro-5-azacytidine in pleural malignant mesothelioma